Back to Search

PAUL WESTERVELT, PHARMD

PHARMD

Pharmacist

NPI: 1508384751Individual

Specialties, Licenses & Credentials

PharmacistPrimary

Pharmacist

Code: 183500000X

03334865(OH)

Research & Publications (20)

Recurring mutations found by sequencing an acute myeloid leukemia genome.
PMID 19657110·N Engl J Med·2009
5-case
Acquired copy number alterations in adult acute myeloid leukemia genomes.
PMID 19651600·Proc Natl Acad Sci U S A·2009
8-other
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes.
PMID 19650118·Am J Hematol·2009
3-trial
Assessment of an alternative meropenem dosing strategy compared with imipenem-cilastatin or traditional meropenem dosing after cefepime failure or intolerance in adults with neutropenic fever.
PMID 19637944·Pharmacotherapy·2009
4-observational
Myeloid growth factors.
PMID 19176207·J Natl Compr Canc Netw·2009
6-review
Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.
PMID 19139740·Bone Marrow Transplant·2009
3-trial
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.
PMID 18987736·Nature·2008
8-other
Myelodysplastic syndromes.
PMID 18926100·J Natl Compr Canc Netw·2008
6-review
Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation.
PMID 18721768·Biol Blood Marrow Transplant·2008
8-other
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction.
PMID 18426988·Blood·2008
3-trial
Somatic mutations and germline sequence variants in the expressed tyrosine kinase genes of patients with de novo acute myeloid leukemia.
PMID 18270328·Blood·2008
8-other
Distinct patterns of mutations occurring in de novo AML versus AML arising in the setting of severe congenital neutropenia.
PMID 17494858·Blood·2007
3-trial
Myeloid growth factors. Clinical practice guidelines in oncology.
PMID 17335688·J Natl Compr Canc Netw·2007
6-review
Clinical response of myelodysplastic syndromes patients to treatment with coenzyme Q10.
PMID 17064768·Leuk Res·2007
3-trial
Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?
PMID 16787120·Future Oncol·2006
6-review
Cellular immune therapy for refractory cancers: novel therapeutic strategies.
PMID 16338484·Exp Hematol·2005
6-review
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.
PMID 15931635·Biol Blood Marrow Transplant·2005
3-trial
High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.
PMID 12750176·Blood·2003
7-preclinical
High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-Hodgkin's lymphoma.
PMID 12665838·Bone Marrow Transplant·2003
3-trial
Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity.
PMID 12463480·Biol Blood Marrow Transplant·2002
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
487 W MAIN ST
WEST JEFFERSON, OH 43162

Location

Practice Location

487 W MAIN ST, WEST JEFFERSON, OH
(614) 879-8500

Quick Facts

NPI
1508384751
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile